Related references
Note: Only part of the references are listed.Innate immune responses triggered by nucleic acids inspire the design of immunomodulatory nucleic acid nanoparticles (NANPs)
Morgan Chandler et al.
CURRENT OPINION IN BIOTECHNOLOGY (2020)
RNA Nanoparticles as Rubber for Compelling Vessel Extravasation to Enhance Tumor Targeting and for Fast Renal Excretion to Reduce Toxicity
Chiran Ghimire et al.
ACS NANO (2020)
Delivery of Anti-miRNA for Triple-Negative Breast Cancer Therapy Using RNA Nanoparticles Targeting Stem Cell Marker CD133
Hongran Yin et al.
MOLECULAR THERAPY (2019)
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Current status of nanomaterial-based treatment for hepatocellular carcinoma
Badriya Baig et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Surface Engineering of Nanoparticles for Targeted Delivery to Hepatocellular Carcinoma
Jingxiong Lu et al.
SMALL (2018)
Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy
Congcong Xu et al.
CANCER LETTERS (2018)
Co-delivery of sorafenib and siVEGF based on mesoporous silica nanoparticles for ASGPR mediated targeted HCC therapy
Guirong Zheng et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
The Effect of Size and Shape of RNA Nanoparticles on Biodistribution
Daniel L. Jasinski et al.
MOLECULAR THERAPY (2018)
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
G. K. Abou-Alfa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Non-coding RNA in drug resistance of hepatocellular carcinoma
Bisha Ding et al.
BIOSCIENCE REPORTS (2018)
The Role of MicroRNAs in Hepatocellular Carcinoma
Xin Xu et al.
JOURNAL OF CANCER (2018)
Nivolumab for the treatment of hepatocellular carcinoma
Fabian Finkelmeier et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rajesha Rupaimoole et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Size, Shape, and Sequence-Dependent Immunogenicity of RNA Nanoparticles
Sijin Guo et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
M. Kudo
LIVER CANCER (2017)
Advancement of the Emerging Field of RNA Nanotechnology
Daniel Jasinski et al.
ACS NANO (2017)
ASGPR-Mediated Uptake of Multivalent Glycoconjugates for Drug Delivery in Hepatocytes
Marie Monestier et al.
CHEMBIOCHEM (2016)
Dextran based nanosized carrier for the controlled and targeted delivery of curcumin to liver cancer cells
Thayyath Sreenivasan Anirudhan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2016)
Modified gold nanoparticles for intracellular delivery of anti-liver cancer siRNA
Hanan Shaat et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Drug delivery system targeting advanced hepatocellular carcinoma: Current and future
Xue Zhang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology
Dan Shu et al.
ACS NANO (2015)
Gum arabic-curcumin conjugate micelles with enhanced loading for curcumin delivery to hepatocarcinoma cells
P. R. Sarika et al.
CARBOHYDRATE POLYMERS (2015)
Liver cancer: Approaching a personalized care
Jordi Bruix et al.
JOURNAL OF HEPATOLOGY (2015)
miR-122-A key factor and therapeutic target in liver disease
Simonetta Bandiera et al.
JOURNAL OF HEPATOLOGY (2015)
MicroRNA-122 mimic transfection contributes to apoptosis in HepG2 cells
Hongyan Huang et al.
MOLECULAR MEDICINE REPORTS (2015)
RNA as a stable polymer to build controllable and defined nanostructures for material and biomedical applications
Hui Li et al.
NANO TODAY (2015)
Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges
Gan-Lu Deng et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Apoptosis in liver cancer (HepG2) cells induced by functionalized gold nanoparticles
Thirunavukkarasu Ashokkumar et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2014)
Polymer-lipid hybrid nanoparticles conjugated with anti-EGF receptor antibody for targeted drug delivery to hepatocellular carcinoma
Jie Gao et al.
NANOMEDICINE (2014)
In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer
Ramona Rudalska et al.
NATURE MEDICINE (2014)
Physiological Roles of Asialoglycoprotein Receptors (ASGPRs) Variants and Recent Advances in Hepatic-Targeted Delivery of Therapeutic Molecules Via ASGPRs
Jing Hu et al.
PROTEIN AND PEPTIDE LETTERS (2014)
Hepatocellular carcinoma review: Current treatment, and evidence-based medicine
Ali Raza et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Radio frequency radiation-induced hyperthermia using Si nanoparticle-based sensitizers for mild cancer therapy
Konstantin P. Tamarov et al.
SCIENTIFIC REPORTS (2014)
Drug Therapy for Advanced-Stage Liver Cancer
Markus Peck-Radosavljevic
LIVER CANCER (2014)
nab-Paclitaxel mechanisms of action and delivery
Denise A. Yardley
JOURNAL OF CONTROLLED RELEASE (2013)
Expression of Asialoglycoprotein Receptor 1 in Human Hepatocellular Carcinoma
Bin Shi et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2013)
Peptide vaccines for hepatocellular carcinoma
Daisuke Nobuoka et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma
Lina Wang et al.
BIOMATERIALS (2012)
Paclitaxel in Cancer Treatment: Perspectives and Prospects of its Delivery Challenges
Somnath Singh et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2012)
MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis
Wei-Chih Tsai et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Pegylated Liposomal Doxorubicin and Gemcitabine in Patients With Advanced Hepatocellular Carcinoma Results of a Phase 2 Study
Giuseppe Lombardi et al.
CANCER (2011)
Thermodynamically stable RNA three-way junction for constructing multifunctional nanoparticles for delivery of therapeutics
Dan Shu et al.
NATURE NANOTECHNOLOGY (2011)
Enhanced Gene Delivery and siRNA Silencing by Gold Nanoparticles Coated with Charge-Reversal Polyelectrolyte
Shutao Guo et al.
ACS NANO (2010)
Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer
Jin Hee Maeng et al.
BIOMATERIALS (2010)
MicroRNA and drug resistance
J. Ma et al.
CANCER GENE THERAPY (2010)
The emerging field of RNA nanotechnology
Peixuan Guo
NATURE NANOTECHNOLOGY (2010)
Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma
Caecilia H. C. Sukowati et al.
WORLD JOURNAL OF HEPATOLOGY (2010)
Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer
Ronnie T. P. Poon et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
MicroRNA-122 Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells and Sensitizes These Cells to Sorafenib
Shoumei Bai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Trivalent, Gal/GalNAc-containing ligands designed for the asialoglycoprotein receptor
Oleg Khorev et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticles
Lifeng Qi et al.
EUROPEAN JOURNAL OF CANCER (2007)
Crystal structure of the carbohydrate recognition domain of the H1 subunit of the asialoglycoprotein receptor
M Meier et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimer
H Maruyama-Tabata et al.
GENE THERAPY (2000)